Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - OraSure Technologies, Inc (NasdaqNM:OSUR)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
July 27Price hit new 52-week high ($15.00)
Location
150 Webster Street
Bethlehem, PA 18015
Phone: (610) 882-1820
Fax: (610) 814-2937
Email: investorinfo@orasure.com
Employees (last reported count): 210
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 41%
·Over the last 6 months:
 · 2 insider sells; 155.0K shares
  (1.0% of insider shares)
·Institutional: 20% (34% of float)
(71 institutions)
·Net Inst. Buying: 2.53M shares (+25.08%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using its proprietary oral fluid technologies, proprietary diagnostic products including in vitro diagnostic tests, and other medical devices. These products are sold in the United States and certain foreign countries to public and private-sector clients, clinical laboratories, physician offices, and hospitals, and for workplace testing. OraSure Technologies' business focuses on the following principal platform technologies: the OraSure oral fluid collection device; the OraQuick rapid diagnostics test device; and the new up-converting phosphor technology. In addition, the Company sells certain other products, including the Histofreezer cryosurgical system, certain immunoassay tests and reagents for insurance risk assessment and forensic toxicology applications, an oral fluid Western Blot confirmatory test for HIV-1, and the Q.E.D. Saliva Alcohol Test.
More from Market Guide: Expanded Business Description

Financial Summary
OraSure Technologies, Inc. develops, manufactures and markets oral specimen collection device, oral fluid assays, proprietary diagnostic products, and other medical devices to healthcare sector customers. For the six months ended 6/30/01, revenues rose 15% to $15.9 million. Net loss rose 23% to $1.4 million. Results reflect continued penetration in the public health market and new product introductions, offset by staff additions and a $450 thousand restructuring charge.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
Robert D. Thompson, CEO
Michael J. Gausling, Pres./COO
Sam Niedbala, Exec. VP
William D. Block, Sr. VP
Richard D. Hooper, VP-Fin./CFO.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:OSURAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Nov-2000
$5.563
Recent Price$13.01 
52-Week High
on 27-July-2001
$15.00 
Daily Volume (3-month avg)158.3K
Daily Volume (10-day avg)89.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
26-Week Change+63.9%
26-Week Change
relative to S&P500
+78.4%
Share-Related Items
Market Capitalization$482.4M
Shares Outstanding37.1M
Float21.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.71 
Earnings (ttm)-$0.36 
Earnings (mrq)-$0.01 
Sales (ttm)$0.86 
Cash (mrq)$0.47 
Valuation Ratios
Price/Book (mrq)18.22 
Price/EarningsN/A 
Price/Sales (ttm)15.19 
Income Statements
Sales (ttm)$30.9M
EBITDA (ttm)-$10.9M
Income available to common (ttm)-$13.0M
Profitability
Profit Margin (ttm)-42.1%
Operating Margin (ttm)-45.0%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-33.62%
Return on Equity (ttm)-48.37%
Financial Strength
Current Ratio (mrq)4.13 
Debt/Equity (mrq)0.20 
Total Cash (mrq)$17.2M
Short Interest
As of 8-Aug-2001
Shares Short594.0K
Percent of Float2.7%
Shares Short
(Prior Month)
808.0K
Short Ratio2.94 
Daily Volume202.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.